NCT02037737View on ClinicalTrials.gov

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting | Biotech Hunter | Biotech Hunter